Use of clomiphene citrate in women (Q44648893)

5 December 2017

Use of clomiphene citrate in women. (English)

1 reference

Practice Committee of the American Society for Reproductive Medicine

5 December 2017

1 reference

series ordinal

1

object named as

Practice Committee of the American Society for Reproductive Medicine

1 reference

PubMed ID

14607612

5 December 2017

language of work or name

English

0 references

publication date

1 November 2003

1 reference

5 December 2017

Fertility and Sterility

1 reference

5 December 2017

80

1 reference

5 December 2017

5

1 reference

5 December 2017

1302-1308

1 reference

Chemical induction of ovulation

5 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

The agonistic-antagonistic properties of clomiphene: a review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Single-dose pharmacokinetics of clomiphene citrate in normal volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Serum concentrations of enclomiphene and zuclomiphene across consecutive cycles of clomiphene citrate therapy in anovulatory infertile women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Evidence for a hypothalamic site of action of clomiphene citrate in women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Hypothalamic-pituitary-ovarian response to clomiphene citrate in women with polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

A prospective randomized trial comparing clomiphene citrate with tamoxifen citrate for ovulation induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Endocrine profiles in tamoxifen-induced ovulatory cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

A randomized double-blind comparison of the effects of clomiphene citrate and the aromatase inhibitor letrozole on ovulatory function in normal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Unexplained infertility: evaluation of treatment with clomiphene citrate and human chorionic gonadotropin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Clomiphene treatment for women with unexplained infertility: placebo-controlled study of hormonal responses and conception rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

A randomized, controlled trial of clomiphene citrate and intrauterine insemination in couples with unexplained infertility or surgically corrected endometriosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Efficacy of treatment for unexplained infertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

The effect of therapy initiation day on clomiphene citrate therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Clinical and laboratory predictors of clomiphene response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Ovulation induction with low doses of clomiphene citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

An extended regimen of clomiphene citrate in women unresponsive to standard therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Pregnancies following use of metformin for ovulation induction in patients with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Menstrual cyclicity after metformin therapy in polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Clomiphene citrate ovulation induction in combination with a timed intrauterine insemination: the value of urinary luteinizing hormone versus human chorionic gonadotropin timing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Prospective, randomized, crossover study to evaluate the benefit of human chorionic gonadotropin-timed versus urinary luteinizing hormone-timed intrauterine inseminations in clomiphene citrate-stimulated treatment cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

A randomized study of dexamethasone in ovulation induction with clomiphene citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Extended clomiphene citrate (CC) and prednisone for the treatment of chronic anovulation resistant to CC alone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Effect of clomiphene citrate upon amount and duration of human menopausal gonadotropin therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

The value of a single serum progesterone measurement in the midluteal phase as a criterion of a potentially fertile cycle ("ovulation") derived form treated and untreated conception cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Ultrasonic observation of the mechanism of human ovulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Comparison of low-technology and high-technology monitoring of clomiphene citrate ovulation induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

A nomogram to predict the probability of live birth after clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Visual disturbance secondary to clomiphene citrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Antiestrogenic effect of clomiphene citrate: correlation with serum estradiol concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Relationship of endometrial thickness and pattern to fecundity in ovulation induction cycles: effect of clomiphene citrate alone and with human menopausal gonadotropin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Clomiphene and Tamoxifen Inhibit Progesterone Synthesis in Granulosa Cells: Comparison with Estradiol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Effects of enclomiphene and zuclomiphene on basal and gonadotrophin-stimulated progesterone secretion by isolated subpopulations of small and large ovine luteal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Effect of clomiphene isomers on progestin synthesis in cultured human granulosa cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

The effects of enclomiphene and zuclomiphene citrates on mouse embryos fertilized in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Multiple pregnancies following induction of ovulation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Outcome of pregnancy after clomiphene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

The outcome of pregnancy resulting from clomiphene-induced ovulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Incidence of spontaneous abortion in clomiphene pregnancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Collaborative Ovarian Cancer Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Ovarian tumors in a cohort of infertile women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Breast and ovarian cancer incidence after infertility and in vitro fertilisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Cancer incidence in a cohort of infertile women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Infertility, fertility drugs, and invasive ovarian cancer: a case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Infertility, Fertility Drugs, and Ovarian Cancer: A Pooled Analysis of Case-Control Studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

Induction of ovulation with cisclomiphene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

7 January 2021

Clomiphene Citrate in the Management of Infertility Associated with Shortened Luteal Phases

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

7 January 2021

Efficacy of clomiphene citrate in the treatment of luteal phase deficiency: quantity versus quality of preovulatory follicles

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

7 January 2021

Interpretation of single progesterone measurement in diagnosis of anovulation and defective luteal phase: observations on analysis of the normal range

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

7 January 2021

Transvaginal sonographic assessment of follicular and endometrial growth in spontaneous and clomiphene citrate cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2803%2901184-1

7 January 2021

10.1016/S0015-0282(03)01184-1

Identifiers

DOI

1 reference

5 December 2017

1 reference

PubMed ID

14607612